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Patterns of physical comorbidity among women with posttraumatic stress disorder (PTSD) were explored
using Michigan Medicaid claims data. PTSD-diagnosed women (n = 2,133) were compared with
14,948 randomly selected women in three health outcome areas: ICD-9 categories of disease, chronic
conditions associated with sexual assault history in previous research, and reproductive health conditions.
PTSD was associated with increased risk of all categories of diseases (OR range = 1.3–4.8), endometriosis
(OR = 2.7), and dyspareunia (OR = 3.4). When PTSD was not complicated by other mental health
conditions, odds ratios for chronic conditions ranged from 1.9 for fibromyalgia to 4.3 for irritable
bowel. Comorbidity with depression or a dissociative or borderline personality disorder raised risk in a
dose–response pattern.
The prevalence of posttraumatic stress disorder (PTSD)
is estimated to be 4.6% among U.S. women, with a 12.3%
lifetime rate (Resnick, Kilpatrick, Dansky, Saunders, &
Best, 1993). This disorder affects women at twice the rate
of similarly traumatic-event-exposed men and becomes
chronic in more than half of affected women (Breslau,
Davis, Peterson, & Schultz, 1997). Although women with
PTSD have been less studied than men, they have reported
worse health perceptions, more functional disability, and
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more physical symptoms (Andreski, Chilcoat, & Breslau,
1998; Kimerling, Clum, & Wolfe, 2000). Physical comor-
bidity with PTSD is believed to occur via psychological, bi-
ological, behavioral, and attentional mechanisms (Schnurr
& Green, 2004). Biological sex, gender socialization, and
menstrual cycle status may be factors in PTSD risk, mor-
bidity, and treatment response as well as patterns of psychi-
atric and physical comorbidity (Rasmusson & Friedman,
2002, Rasmusson et al., 2001). Current knowledge of
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physical comorbidity with PTSD among women is based
on survey studies of health perceptions (e.g., Kimerling
et al., 2000) and case-control studies of patients of both
genders with specific physical conditions such as irritable
bowel syndrome (e.g., Irwin et al., 1996), or small samples
of medical patients who often are veterans (e.g., Ouimette
et al., 2004).
The goal of this analysis was to explore patterns of
physical comorbidity with PTSD among a population of
women via descriptive epidemiological analysis of Medi-
caid service-use data. The analysis focused on three sets of
health outcomes: categories of disease, five chronic con-
ditions (i.e., chronic fatigue, fibromyalgia, irritable bowel,
chronic pelvic pain, and menstrual pain) associated in nu-
merous previous studies with a history of sexual abuse
or assault, and reproductive problems. This analysis con-
sidered some of the additional elements contributing to
the complexity of this phenomenon, to the extent feasi-
ble with service-use data. We controlled for the effects of
sex and gender (by limiting the study to women), poverty
and access to health care (by studying Medicaid recipients
and controlling for extent of coverage), age and reproduc-
tive stage of life (by stratifying into reproductive-age and
postmenopausal-age groups), psychiatric comorbidity (by
controlling for depression and other psychiatric diagnoses
and differentiating more severe cases of PTSD, those that
have depressive comorbidity, and those that likely have
complex PTSD), and recent victimization (discerned via
coding for victim services).
M E T H O D
Design and Data Source
This is a case-control analysis of an existing public health
insurance health-service-use database comparing every
adult female recipient with the PTSD diagnostic code
(n = 2,133 cases) and 14,948 randomly selected compari-
son women recipients without a PTSD diagnosis. The data
are from the state of Michigan’s Medicaid program. This
database is in the public domain and was made available
for research as a delimited dataset, under a data-use agree-
ment, consistent with Health Insurance Portability and
Accountability Act regulations (HIPAA, 1996) and with
Institutional Review Board approval, by Health Manage-
ment Associates of Lansing Michigan.
Medicaid is the public program providing health insur-
ance coverage for people who live in poverty and do not
have private insurance. Eligibility is based on demonstrated
need and must be periodically renewed. The Medicaid el-
igibility data contain demographic information limited to
date of birth, gender, self-reported race, county of resi-
dence, and postal code area. They also indicate dates of
coverage, type of program (fee-for-service or capitated),
and general reason for public insurance eligibility, includ-
ing disability, but with no information about the type or
cause of disability. The claims databases include numer-
ical coding for diagnoses [International Classification of
Diseases, 9th ed. (ICD-9); Practice Management Informa-
tion Corporation, 1998], procedures (Current Procedural
Terminology, CPT), and drugs (National Drug Classifica-
tion) for purposes of processing payment to institutions
and practitioners for inpatient, ambulatory, and pharmacy
services. They include mental health services delivered by
providers eligible by state law to provide services including
primary care physicians and advance practice nurses, social
workers, psychologists, and psychiatrists. Norms dictate
that the diagnoses recorded be a focus of the hospitaliza-
tion or encounter, whether tentative or confirmed.
The data in this analysis are for 1994–1997 Medicaid-
covered services for recipients who had coverage exclusively
from a fee-for-service program. Capitated (monthly flat-
fee program) records were eliminated because Michigan’s
capitated Medicaid programs have “mental health carve
outs,” whereby physical health services are capitated (i.e.,
not coded in detail), but mental health services are charged
in the traditional “fee-for-service” manner. This results in
cases where mental health diagnoses exist in the record, but
no medical diagnoses appear, requiring exclusion of these
cases from this analysis. The first year when the cleaned
tables are available for the full population of recipients is
1994. After 1997, the proportion of capitated cases became
high enough to introduce a sampling bias since healthier
people are more likely to change coverage and move to
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HMO-style programs (D. Roberts, Health Management
Associates, personal communication, September 6, 2001).
There is no way to know what, if any, services recipients
used beyond the services covered by Medicaid, but among
poor people, the proportion of health care services paid for
out-of-pocket is likely to be small.
Sample and Power Analysis
Claims records for every female recipient with the ICD-9
diagnostic code for PTSD (n = 4,894) were extracted out
of the entire female Michigan Medicaid population (ap-
proximately 900,000 enrolled per year) across the 1994
through 1997 time period to determine the prevalence of
the PTSD diagnosis for females of all ages (0–94 years
old). To achieve adequate power for low-prevalence con-
ditions, we wanted at least a 3:1 ratio of comparison to
case records (Hulley et al., 2001) across all age groups, in-
cluding the late adolescent peak for PTSD (Breslau et al.,
1997). Thus, we extracted comparison records via ran-
dom number assignment from all remaining females in a
10:1 ratio (n = 48,940). After excluding records with any
months in capitated programs, 3,816 PTSD case records
and 27,366 comparison records remained, and the desired
3:1 ratio was achieved in all age strata. This report focuses
on the analysis for adults in two age strata: reproductive-
age (18–54 years) and postmenopausal-age (>54 years)
women with results for children and adolescents (Seng,
Graham-Bermann, Clark, McCarthy, & Ronis, 2005) and
a health disparities analysis (Seng, Kohn-Wood, & Odera,
2005) reported elsewhere.
Power analysis was done with the PASS 2000 software
program (Cohen, 1988; Hintze, 2000). To determine sam-
ple size required, we assumed at least 10% in the PTSD
case group, a two-tailed alpha of .05, and power of 80%.
With a conservative odds ratio (2.4) and 25% of variance
explained by other predictors, the sample size needed to
test the lowest prevalence disorder (2%) is 3,600. Within
the postmenopausal-age group (> 55), the sample size was
3,325, but this includes only 44 women with the PTSD
diagnosis, so descriptive and bivariate analyses only were
conducted for that group.
Data Analysis
Demographic variables available included gender, age, eth-
nicity, and program and coverage information from the
eligibility table. Most other variables were created out
of inpatient and practitioner claims tables from individ-
ual codes (e.g., PTSD Code 309.81) or ranges of codes
(e.g., infectious disease Codes 001–139) in the ICD-9 tax-
onomy (Practice Management Information Corporation,
1998). The victimization and mental health treatment vari-
ables were created from visit codes (e.g., for counseling
with a victim of abuse), explanation codes (e.g., explain-
ing the means of an injury to be battering), procedure
codes (e.g., psychotherapy), and pharmacy codes (e.g.,
drug class).
Bivariate case-control analyses of prevalence rates and
odds ratios were done using t test or chi-square. These
comparisons were done by age strata with range of
ages determined based on likely reproductive status be-
cause several of the conditions of interest occur pri-
marily prior to menopause (e.g., menstrual pain, en-
dometriosis) or after menopause (e.g., cardiac disease,
osteoporosis).
A series of multivariate logistic regression models were
specified to determine the effect of PTSD exposure on
the health outcomes using a limited number of covariates.
Choice of covariates was made using a change-in-estimate
approach (Greenland, 1989). The effect of age and repro-
ductive status is addressed by stratifying, limiting multi-
variate analysis to reproductive-age women only. Two other
covariates, race and exposure to insurance, were included
(exposure to insurance) or excluded (race/ethnicity) based
on the Mantel-Haenszel test of conditional independence
and the Breslow-Day test of homogeneity of the odds ra-
tios to assess confounding and effect modification, respec-
tively (Agresti, 1990; Breslow & Day, 1993). The hospital
victim-service code was selected as a covariate a priori be-
cause it is an important potential alternative explanation
for the outcomes. The primary predictor in the multivari-
ate analysis was a six-category mental health variable that
divides the comparison and case groups into three cate-
gories each. Comparison women are designated as having
Journal of Traumatic Stress DOI 10.1002/jts. Published on behalf of the International Society for Traumatic Stress Studies.
48 Seng et al.
(a) no mental health diagnosis, (b) a mental health diagno-
sis that is neither PTSD nor depression, or (c) depression
without PTSD. The case group is designated as having (d)
PTSD without depression, (e) PTSD with depression, or
(f ) PTSD (with or without depression) in conjunction with
either a dissociative or a borderline personality disorder di-
agnosis. This predictor controls for psychiatric comorbid-
ity and addresses the alternative hypotheses that it is not
PTSD, per se, but rather having depression, having a mental
disorder in general, or having only severe PTSD that is as-
sociated with these adverse health outcomes. These models
were estimated in a hierarchical manner, with the coverage
and victimization variables entered first and then the PTSD
categorical variable, to compare the effects of victimization
alone and then victimization and PTSD together. The ad-
justed odds ratios were calculated for all three sets of health
outcomes.
R E S U L T S
Demographic and Psychiatric Characteristics
The annual prevalence of PTSD diagnosis among all fe-
male (child and adult) Michigan Medicaid recipients was
0.45% in 1994 and rose to 0.50% in 1997. Table 1 de-
scribes the demographic, health services, and psychiatric
characteristics of the PTSD and comparison groups by
age strata. Among postmenopausal recipients, the mean
age of the PTSD-diagnosed group was 10 years younger
than the comparison group (62 vs. 72), F (1, 3323) =
42.7, p < .001. While statistically significant, the mean
age of PTSD-diagnosed recipients in the reproductive-age
stratum was only slightly older (1 year) than recipients in
the comparison group. Among reproductive-age women,
the PTSD-diagnosed group had more months of coverage.
PTSD-diagnosed women in the postmenopausal group
did not differ with regard to coverage. PTSD-diagnosed
women in both age strata were twice as likely to be eligible
for Medicaid due to disability. African American women
were only 11.9% of the reproductive-age PTSD-diagnosed
recipients while they represent 28.2% of that comparison
group, χ2(1, N = 13,756) = 248.1, p < .001, a differ-
ence which has been studied in a separate analysis (Seng,
Kohn-Wood, & Odera, 2005).
Among the 13,756 recipients in the reproductive-age
group, coding for hospital encounters related to victimiza-
tion occurred 320 times, with 9.1% of the PTSD group and
1.1% of comparison recipients having hospital episodes
due to inflicted injury, or rape, χ2(1, N = 13,756) =
496.7, p < .001. Rates of victimization coding ranged
from 0.6% among those with no mental health diagno-
sis to 4.4% with depression but not PTSD, to 5.3% with
PTSD but not depression, and to 19.5% among those with
complex PTSD. One third of the codes for rape or inflicted
injury occurred after the first date of the PTSD diagnosis
code, indicating a potential revictimization.
In the randomly selected comparison group, the preva-
lence of any and all non-PTSD psychiatric codes in the
ICD-9 taxonomy range 290 to 319 (including, thus, those
with organic conditions such as dementia and mental re-
tardation) was 27% in the reproductive-age stratum and
40.3% among the postmenopausal women. Prevalence
of mental health disorders considered to be comorbid
with PTSD or its associated features were higher in the
PTSD case group, as were two severe mental illnesses
(i.e., bipolar disorder and schizophrenia, see Table 1).
Odds of suicide, attempted suicide, and self-inflicted in-
jury were 18.1 times as great in the PTSD-diagnosed
group (0.2 vs. 3.7% prevalence, 95% CI = 11.5, 28.4
or 11.5–28.4).
To consider PTSD chronicity, we used the three mental
health diagnosis subgroups within the PTSD case group:
(a) those who had a PTSD diagnosis but no depression, dis-
sociation, or borderline personality comorbidity, or “simple
PTSD;” (b) those who had codes for both PTSD and de-
pression; and (c) those who had PTSD and also either a
dissociative disorder or a borderline personality disorder
diagnosis, or “complex PTSD.” This subgroup categoriz-
ing of PTSD-diagnosed women showed a dose–response
pattern for length of duration of the PTSD code appearing
in the data (see Table 1). Duration of PTSD coding likely
reflects duration of PTSD treatment, which can be affected
by resolution of the condition, treatment dropout, loss of
coverage, or shift of focus of treatment away from PTSD.
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Table 1. Demographic and Psychiatric Characteristics of the Two Age Strata by PTSD Case or
Comparison Group Status
Reproductive Age: 18–54 Postmenopause: 55+
Comparison PTSD Comparison PTSD
Age
Mean 30 31∗∗∗ 72 62∗∗∗
Median 28 30 71 60
Mode 20 30 70 55
Medicaid coverage
Mean number of months 22 34∗∗∗ 32 36
Percent with continuous coverage 9.8% 24.9%∗∗∗ 31% 45.5%∗
Ethnicity
White 63.8% 83.2% 61.1% 72.7%
African American 28.2% 11.9%a 22.4% 13.6%
Asian 1.2% 0.3% 2.1% 0.0%
Hispanic 4.0% 1.6% 0.9% 4.5%
Native American 0.5% 0.9% 0.2% 2.3%
Other 2.3% 2.1% 8.3% 6.8%
Eligibility via disability 18.0% 40.0%∗∗∗ 33.0% 61.0%∗∗∗
Code for victimization 1.1% 9.1%∗∗∗ 0.1% 0%
Mean days duration of PTSD coding
PTSD only (n = 753) n/a 144 n/a 104
PTSD + Depression (n = 957) n/a 175 n/a 324
Complex PTSD (n = 379)b n/a 285 n/a 345
Treatment use
SSRI antidepressant 18.1% 71.5%∗∗∗ 22.6% 68.2%∗∗∗
Psychotherapy 5.0% 37.4%∗∗∗ 3.4% 20.5%∗∗∗
Comorbidity or associated features
Depression 9.4% 61.7%∗∗∗ 4.8% 43.2%∗∗∗
Anxiety 4.7% 30.1%∗∗∗ 2.5% 25.0%∗∗∗
Substance abuse 6.8% 23.6%∗∗∗ 1.0% 4.5%
Eating disorder 0.2% 2.7%∗∗∗ 0.1% 0.0%
Dissociation 0.3% 7.6%∗∗∗ 0.0% 2.3%∗∗
Somatization 0.0% 0.8%∗∗∗ 0.0% 0.0%
Borderline personality disorder 0.6% 13.9%∗∗∗ 0.2% 4.5%∗∗
Severe mental illness
Schizophrenia 3.1% 13.4%∗∗∗ 5.1% 2.3%
Bipolar disorder 1.7% 16.6%∗∗∗ 1.8% 11.4%∗∗∗
Note. Significance test by Fisher’s exact test when cell size is <5.
aChi-square test of proportion of African American versus White is significant at p < .001. bFor reproductive age group one-way ANOVA,
F (2, 2086) = 31.5, p < .001. Scheffe post hoc test indicates PTSD without depression vs. PTSD with depression difference not significant
(p = .069), but contrasts with Complex PTSD are significant at p < .001. For postmenopausal group one-way ANOVA, F (2, 41) = 3.6,
p < .05. Scheffe post hoc test indicates PTSD without depression vs. PTSD with depression contrast is significant at p = .050.
∗ p < .05.∗∗ p < .01. ∗∗∗ p < .001.
The complex PTSD group’s mean duration of PTSD cod-
ing was significantly longer by 3 to 4 months (M = 285
days, S D = 392 days, respectively; F (2, 2086) = 31.5,
p < .001, in both comparisons. The rate of suicide or self-
inflicted injury coding increased from 0.7% in the PTSD
without depression category to 2.8% in the PTSD with
depression category, and to 12.1% in the complex PTSD
category.
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Disease and Chronic Conditions Among
Postmenopausal Women With PTSD
Only 44 recipients in the postmenopausal-age group had a
PTSD diagnosis. The PTSD-diagnosed older women had
significantly higher rates of coding than the older com-
parison group women in the following disease categories
after Bonferroni correction for multiple comparisons (p <
.003; Pedhazur & Schmelkin, 1991): digestive (OR = 3.7);
genitourinary (OR = 2.6); musculoskeletal and connective
tissue (OR = 5.6); and signs, symptoms, and ill-defined
conditions (OR = 3.4). They also had significantly higher
rates of chronic pelvic pain (OR = 6.1). (Prevalence rates
for all outcomes are available from the corresponding
author.) The rest of the results presented pertain to the
reproductive-age group.
Disease, Chronic Conditions, and Gynecologic
Problems Among Reproductive-Age Women With PTSD
Among reproductive-aged, PTSD-diagnosed women, cod-
ing occurred for every category of disease, all five chronic
conditions, and each of the gynecologic health problems at
significantly higher rates (p < .002 after Bonferroni cor-
rection for 23 comparisons). (Prevalence rates are available
from the corresponding author.) Bivariate odds ratios in the
categories of disease were between 1.3 (blood and blood
forming organs) and 4.8 (signs, symptoms, and ill-defined
conditions), and they ranged from 2.4 (fibromyalgia) to 4.7
(irritable bowel syndrome) among the chronic conditions
in previous research that were associated with a history of
sexual abuse or assault. The PTSD-group’s mean number
of chronic-condition diagnoses was 0.73 (vs. 0.26), F (1,
13756) = 1050.2, p < .001. The PTSD group had twice
the rate of having one of the chronic-condition diagnoses,
4 times the rate of having two, and 7 and 11 times the
rates of having three and four such diagnoses, respectively,
a level and distribution of symptomatology which, absent
organic findings, could potentially meet diagnostic cri-
teria for somatiform disorders. PTSD-diagnosed women
also had increased odds for gynecologic conditions rang-
ing from 1.5 for any sexually transmitted infection to 3.4
for dyspareunia, but they had fewer pregnancies (OR =
0.60). In every health outcome comparison for the cate-
gories of diseases and chronic conditions, the prevalence
rate was lowest in the reference group (i.e., women with
no mental health diagnosis). Within the PTSD-diagnosed
group, there also was a consistent dose–response pattern
related to PTSD severity.
Multivariate Models of Effects of Insurance Coverage,
Victimization, and PTSD Status on Health Outcomes
We estimated stepwise logistic regression models for all 23
outcomes in the reproductive-age group, estimating first
the effect of victimization controlling for exposure to Med-
icaid coverage. Victimization alone conveyed statistically
significantly increased odds for most conditions, after ad-
justing for exposure to Medicaid coverage (Table 2). When
the six-category PTSD variable that distinguished women
with depression and complex PTSD was added to these
models (using women with no mental health diagnosis as
the reference group), it generally weakened the association
with victimization and sometimes made the victimization
variable lose statistical significance, suggesting that PTSD
may sometimes act as a mediator of health outcomes (Baron
& Kenny, 1986). Once PTSD was entered into the model,
victimization was not significantly associated with any of
the five chronic conditions previously associated with sex-
ual assault or sexual abuse history, except for chronic pelvic
pain.
In relation to the six-category case-control variable, the
odds ratios for the health outcomes generally followed
a dose–response pattern. The PTSD cases without
depressive, dissociative, or borderline personality disorder
comorbidity (“simple PTSD”) are more at risk than the ref-
erence category of no mental health diagnosis. Depression
without PTSD and simple PTSD vary in terms of which is
more strongly associated with the chronic and reproductive
conditions. PTSD with depression is usually more strongly
associated with ill health than depression alone. The
most severe category, complex PTSD, has the strongest
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associations with all ICD-9 disease categories except skin
disorders. Among the chronic conditions associated with
previous sexual assault or sexual abuse, irritable bowel and
chronic pelvic pain are associated with PTSD, and chronic
fatigue may be associated with PTSD, but fibromyalgia and
menstrual pain appear to be more strongly associated with
depression. Endometriosis and dyspareunia are associated
with PTSD and not victimization, but the relationships
with PTSD and the other gynecological conditions are less
clear. The pregnancy rate is negatively related to PTSD
severity (or to PTSD treatment). Overall, the multivariate
models suggest that the extent to which PTSD, depression,
and victimization are associated with adverse health out-
comes varies, and differing behavioral and biological path-
ways may be implicated. For the majority of conditions,
PTSD in its chronic, psychiatrically comorbid, complex
forms increases risk for health problems above and beyond
the risk contributed by either victimization or depression—
two factors already considered to be seriously detrimental
to women’s health across the life span.
D I S C U S S I O N
The results of this descriptive epidemiological analysis
indicate that PTSD was associated with adverse health
outcomes throughout adulthood among female Medicaid
recipients, including indication of greater disease morbid-
ity at an earlier age among postmenopausal recipients.
This analysis found, similar to many other studies, that
victimization increased risk for adverse health outcomes,
but it also showed that PTSD appeared to be a stronger
predictor than victimization for nearly all of these con-
ditions. Findings from earlier, primarily survey research
studies have shown that women with PTSD have more
symptoms, worse health perceptions, and more functional
disability. This descriptive epidemiological analysis of pub-
licly insured women with a PTSD diagnosis extends this
research by showing that (a) this pattern applies to con-
ditions for which women seek care and receive diagnoses
in health care settings and that (b) physical comorbidity
occurs in a dose–response relationship with PTSD severity
and chronicity.
Limitations
The prevalence of PTSD diagnosis in these data (0.5%)
is far below the 4.6% rate of PTSD estimated from an
epidemiological study of U.S. women from roughly the
same time period (Resnick et al., 1993). Reasons for un-
derdiagnosis cannot be discerned from administrative data.
Because of this underdiagnosis, many women with PTSD
may be in the comparison group, including the group with
depression. Thus, these results may overestimate the ef-
fect of depression alone and underestimate the importance
of PTSD, and the pattern of health outcomes associated
with PTSD could be somewhat different. Because most of
the PTSD group was in psychotherapy or using a selective
serotonin reuptake inhibitor, these results also may under-
estimate the effects on health of PTSD that is untreated
or the effect of PTSD on medical care seeking among
women who do not have a relationship with a mental
health provider.
These findings must be considered to be preliminary
in nature due to limitations inherent in service-use data
and cross-sectional analysis. Rates of hospital coding for
victimization are lower than rates of actual occurrence of
victimization, and other trauma exposures not considered
in this analysis also could be the antecedent for PTSD.
PTSD itself was likely underdiagnosed. Thus, the relative
magnitude and specific patterns of trauma exposure and
PTSD in relation to physical health problems could differ
in studies with more comprehensive means of measuring
both trauma-exposure history and PTSD. Some cases of
PTSD may have been diagnosed only subsequent to ex-
periences of medical traumatic events (e.g., breast cancer
diagnosis and/or treatment), introducing a proportion of
error in inference about causality that could be reduced in
designs where the nature of the antecedent traumatic event
can be assessed. Coding errors occur, and their propor-
tion cannot be estimated; however, this error likely would
be random. Services not paid for with Medicaid cover-
age will not be noted in this analysis. Administrative data
show actual patterns of utilization without differentiating
tentative from confirmed diagnoses. Future studies with
physical examination and laboratory data will be needed
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to understand patterns of confirmed diagnoses and their
biological mechanisms.
The limitations of using naturalistic data in an ex-
ploratory study are balanced by the lack of the sorts of
error and bias that can occur when data are collected in
the context of a research study. Patterns can be seen across
a broad array of conditions, and conclusions are based on
actual patient care seeking and clinician practice. Inference
from this epidemiological, secondary analysis is strength-
ened by the number of records included, by the fact that
all PTSD cases were used rather than a sample of them,
and by comparing PTSD-diagnosed women with all others
rather than only with (psychiatrically) healthy controls.
Generalizability
Overall, according to 2000 Census data (U.S. Census
Bureau, n.d., http://factfinder.census.gov), Michigan’s so-
ciodemographic profile is similar to the U.S. population
with regard to gender, age, educational attainment, and
workforce participation. Findings from Michigan Medi-
caid data can reasonably be generalized to the U.S. popu-
lation of Medicaid recipients because the state’s eligibility,
enrollment, and demographic profile in the 1990s was
very similar to that of the aggregate U.S. Medicaid pro-
gram (Health Care Financing Administration, 1996, 1997;
Winterbottom, Liska, & Obermaier, 1995). These find-
ings may not be generalizable to insured women; however,
in HMO studies, privately insured traumatic-event sur-
vivors also have been found to have higher utilization rates
and costs (Walker et al., 2003). In one study that com-
pared medical care seeking by insurance status, privately
insured women with a sexual-assault history sought care at
slightly higher levels than their Medicaid-insured counter-
parts (59.4% privately insured vs. 54.4% Medicaid-insured
6-month medical service utilization rate; Golding, Stein,
Siegel, Burnam, & Sorenson, 1988). Replication of this
analysis with insurance industry data would be useful.
It is more difficult to determine if rates of victimization
are representative. With regard to current violent-crime
exposures, the Michigan annual rate was 10% higher than
the U.S. rate in 2003, but both rates equate to roughly
0.5% per year (511 vs. 475 cases, respectively, of murder,
forcible rape, robbery, or aggravated assault per 100,000
according to FBI statistics [The Henry J. Kaiser Family
Foundation, 2003]). The overall rate in these data among
the 18- to 54-year-olds for codes for hospital encounters for
rape and inflicted injury for the 4-year period was 2.3%,
suggesting underdetection. Low-income women could be
expected to live in more high-crime environments, but not
all violent crimes result in hospital encounters.
This sample also is distinguished by high rates of dis-
ability in the PTSD group. Michigan and U.S. rates of
self-reported disability in 2000 Census data (U.S. Census
Bureau, n.d.) for all people age 5 years and older are sim-
ilar (18.7 and 19.3%, respectively), with 5.2 versus 4.8%,
respectively, reporting mental disability and 10.7 versus
11.9%, respectively, reporting employment disability. In
the 16- to 64-year census age group, disabled people were
twice as likely (18.8 vs. 9.6%, respectively, to live below
the federal poverty level, making them eligible for Medi-
caid coverage (Waldrop & Stern, 2003). In the Michigan
Medicaid data used for this analysis, 21.6% of the women
overall were eligible for Medicaid due to disability, with
18% in the comparison group and 40% in the PTSD
group. From these data, it is not possible to know the ex-
tent to which the PTSD group’s higher rate reflects greater
mental health disability, greater physical disability from
traumatic events that also increase risk for PTSD (e.g.,
motor vehicle accidents, fires, life-threatening illness, and
crime), or both.
Finally, clinician diagnosis of PTSD in these data would
appear to underdiagnose PTSD to an extent that it could
plausibly be only the most severe cases that are identified. If
this were the case, this source of error could result in Type I
error (i.e., concluding that PTSD is associated with adverse
health outcomes when the relationship really only occurs
with severe PTSD). Use of the six-category mental health
variable provides information to show that a range of sever-
ity of PTSD cases did appear to be identified. This increases
support for the general conclusion that PTSD is associ-
ated with these health conditions because a dose–response
pattern is visible, with even “simple PTSD” associated
with adverse outcomes. Nevertheless, these conclusions
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likely should be considered to apply only to treatment-
seeking women with PTSD. Further research with sys-
tematic diagnostic procedures and community samples is
needed.
Implications
Clinical research can address the limitations of this descrip-
tive epidemiological analysis by systematically determining
traumatic-event exposure, PTSD diagnosis, and psychiatric
comorbidity, by including biological indicators of multi-
ple stress systems’ functioning, by differentiating tentative
from confirmed diagnoses for physical conditions, and by
including both clinical and community samples. Future
designs also should attempt to capture instances when un-
derutilization from PTSD-related avoidance of appropri-
ate medical care (e.g., pap tests, mammograms, and blood
tests) resulted in adverse outcomes (Schnurr & Green,
2004). Observational studies that measure and model the
impacts of psychotherapy, medication, and instances of in-
tegrated mental health and medical treatment would pro-
vide effect size data for future clinical trials of PTSD-related
interventions to improve physical health conditions. Fu-
ture designs ideally also would consider whether traumatic
events and PTSD are causally related to these physical con-
ditions or whether the stress-regulation systems’ alterations
seen across these conditions are, instead, a shared vulner-
ability for both PTSD and ill health (Heim, Ehlert, &
Hellhammer, 2000). The relative roles of depression and
PTSD in relation to onset of ill health are important to
discern in future studies.
Anxiety disorders, including PTSD, have been asso-
ciated with high levels of medical utilization, cost, dis-
ability, and suicide mortality regardless of whether mental
health treatment occurred (Greenberg et al., 1999). Find-
ings from this study confirm that primary prevention of
trauma exposures and secondary prevention of PTSD are
critical priorities to meet both public health and medi-
cal cost-containment goals. Focus on the health effects of
PTSD may be especially beneficial in populations where
trauma exposure and mental health sequelae are most se-
vere, and where case-finding efforts should be routine,
including severely mentally ill and substance-dependent
women, homeless women, and those connecting with rape
crisis and domestic violence programs. It also is evident
from this analysis, where PTSD cases were identified most
often in mental health settings, that mental health profes-
sionals may be able to play an appropriate role in their
patients’ physical health and medical care. More models
for collaborative treatment are needed, as are studies of
physical health outcomes of psychological and pharmaco-
logical treatments for PTSD. If PTSD were more often
recognized as a factor in women’s healthcare encounters
and treated as early in the life span as possible, then the ill
effects on health that were associated in this analysis in a
dose–response pattern might be decreased.
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